As treatment options continue to improve and evolve, many haematologists are looking towards the use of combination therapies when treating Immune Thrombocytopenia (ITP).
As treatment options continue to improve and evolve, many haematologists are looking towards the use of combination therapies when treating Immune Thrombocytopenia (ITP).
“Take a deep breath” might be some of the best advice around. It’s one of the easiest and most effective ways to relieve stress, and has been for thousands of years.
Get to know some of our members worldwide as they help raise awareness for ITP and support ITP patients and their communities.
Clinical trials are the backbone of medical research, providing critical insights and advancements in treating various conditions, including immune thrombocytopenia (ITP).
The International Society on Thrombosis and Haemostasis (ISTH) 2024 Congress, held in the vibrant city of Bangkok, Thailand, was a landmark event in the field of haematology.
Stassi Austin attended the 2024 ITP patient Conference in Canberra, ACT, from her home state of South Australia. Here’s what she thought about this year’s conference.
On 25 July 2024, Aotearoa, New Zealand, witnessed a landmark event when it released its first Rare Disorders Strategy. You can get your copy of the strategy here.
Travelling can be an exciting adventure, but as someone living with Immune Thrombocytopenia (ITP), it requires careful planning and preparation, regardless of the destination.
Scientists in the Gardiner Group of the John Curtin School of Medical Research (JCSMR) have successfully performed platelet function assessment of all the patient attendees of the ITP Patient Conference 2024.